Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Change in Cash (2016 - 2025)

GeoVax Labs' Change in Cash history spans 16 years, with the latest figure at -$1.9 million for Q4 2025.

  • Quarterly results put Change in Cash at -$1.9 million for Q4 2025, up 37.67% from a year ago — trailing twelve months through Dec 2025 was -$2.4 million (down 156.04% YoY), and the annual figure for FY2025 was -$2.4 million, down 156.04%.
  • Change in Cash for Q4 2025 was -$1.9 million at GeoVax Labs, down from $1.9 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $14.6 million in Q2 2022 to a low of -$7.1 million in Q4 2022.
  • The 5-year median for Change in Cash is -$1.7 million (2021), against an average of -$339902.8.
  • The sharpest move saw Change in Cash surged 17909.64% in 2021, then plummeted 648.01% in 2025.
  • Year by year, Change in Cash stood at -$6.7 million in 2021, then dropped by 5.7% to -$7.1 million in 2022, then increased by 11.75% to -$6.2 million in 2023, then surged by 50.51% to -$3.1 million in 2024, then skyrocketed by 37.67% to -$1.9 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$1.9 million, $1.9 million, and -$4.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.